| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT02051062 | BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients | Botulism | Enrolling by Invitation |
| NCT02177721 | Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational… | Infections, Bacterial | Not Yet Recruiting |
| Not specified | |||
| NCT07268612 | Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for… | Anthrax | Not Yet Recruiting |
| NCT03569514 | Observational Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in… | Anthrax | Not Yet Recruiting |
| NCT03569553 | A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in… | Inhalational Anthrax | Not Yet Recruiting |
| NCT07478471 | Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax | Infections, Bacterial | Not Yet Recruiting |
| NCT01374984 | VA-005 Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or… | Complication of Smallpox Vaccination | Enrolling by Invitation |